Article Details

SSc-ILD Treatment Market 2034: EMA, PDMA, FDA Approvals, - openPR.com

Retrieved on: 2025-02-22 12:34:08

Tags for this article:

Click the tags to see associated articles and topics

SSc-ILD Treatment Market 2034: EMA, PDMA, FDA Approvals, - openPR.com. View article details on hiswai:

Excerpt

Systemic Sclerosis-associated Interstitial Lung Disease Companies in the market are Roche, Prometheus Biosciences, Inc., MERCK, GlaxoSmithKline, ...

Article found on: www.openpr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo